Fisetin, a flavonoid derived from Rhus succedanea L., induces apoptosis of human bladder cancer by increasing the ratio between pro-apoptotic and anti-apoptotic proteins by upregulating p53 and downregulating NF-κB activity in T24 and EJ bladder cancer cells. The gene discussed is TP53; the disease is urinary bladder cancer.